Cannabis Sativa

October 12, 2016October 12, 2016 thcscience_admin

3,5-dimethyl-2-phenylmorpholine (PDM-35)
Legal status

Legal status	CA: Unscheduled DE: NpSG (Industrial and scientific use only) UK: Under Psychoactive Substances Act US: Analogue to a Schedule I/II drug
Identifiers
IUPAC name 3,5-dimethyl-2-phenylmorpholine
CAS Number	1218345-44-8
PubChem CID	43367115
DrugBank	Provide Please Provide
UNII	B5FRU2US8C
Provide&page2=PDM-35 (verify)

2-Phenyl-3,5-dimethylmorpholine is a drug with stimulant and anorectic effects, related to phenmetrazine. Based on what is known from other phenylmorpholines with similar structure, it likely acts as a norepinephrine-dopamine releasing agent and may produce effects similar or slightly different to phenmetrazine.^[1]

See also[edit]

3-Fluorophenmetrazine
G-130 (2-Phenyl-5,5-dimethylmorpholine)
3,4-Phendimetrazine (2-Phenyl-3,4-dimethylmorpholine)
3,6-Phendimetrazine (2-Phenyl-3,6-dimethylmorpholine)
4-Methylphenmetrazine
Manifaxine
Radafaxine
Viloxazine

References[edit]

^ HU 219458, Boswell GE, Kelley JL, Mehta NB, "2-phenyl-3,5-dimethyl morpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them.", published 28 April 2001, assigned to Wellcome Foundation Ltd.

source: https://en.wikipedia.org/wiki/PDM-35

Leave a Reply

You must be logged in to post a comment.